# Apollo Neuroscience: company

Canonical ID: `059eabe2-358b-46bd-96ed-761280ef9052`

## Key facts

- **Founded:** 2020, Pittsburgh, Pennsylvania
- **Founders:** David Rabin MD PhD (Chief Innovation Officer), Greg Siegle PhD (Chief Scientific Officer)
- **Product:** Apollo Neuro - wearable touch therapy device delivering low-frequency vibration patterns to improve sleep, stress resilience, and focus
- **Funding:** Seed $5M; Series A $15M; total ~$20M
- **Science:** Based on Dr. Rabin research at University of Pittsburgh on touch therapy for PTSD and stress; clinically tested HRV improvement
- **Differentiation:** Vibroacoustic touch therapy rather than tracking; active intervention device; psychiatric research foundation

- **Slug:** apollo-neuro

## Models

- [Apollo Neuro](/models/apollo-neuro-device.md) (biometric) (id: `9d122eb8-674a-4600-8f5e-63e4ab127a16`)

## Current leadership (2)

- [David Rabin MD PhD](/people/david-rabin.md) founder (secondary-verified)
- [Greg Siegle PhD](/people/greg-siegle.md) founder (secondary-verified)

## Supplies to

_No verified supply relationships on file. Supply-chain coverage is being added across the registry; check back as the seed populates this company's outbound edges._

_Outbound supply edges. Each appears when verified with at least two strong sources. Sources are append-only; corrections add new sources rather than rewrite history._

## Sources (2)

1. https://www.apolloneuro.com/
2. https://www.forbes.com/sites/forbesbusinesscouncil/2023/04/12/wearable-technology-for-stress-management/

_API: GET /v1/companies/059eabe2-358b-46bd-96ed-761280ef9052 · canonical URL: /companies/apollo-neuro_